Pfizer signs up for match-making service; Investors tell Sanofi: Make a deal, now
• Pfizer has signed on with a “match-maker” group in Cambridge UK that specializes in bringing biopharma companies and academic investigators together. The Milner Therapeutics Consortium was set up in 2015, attracting GSK and AstraZeneca, among others, to the fold.
• Sanofi promised new M&A deals, but just can’t seem to pull a big one off. Two deals have slipped away now. And some of its big investors are getting worked up about the lack of progress under CEO Olivier Brandicourt. “The company needs a growth driver and must make an acquisition. Time is running out,” Olivier David of Vega Investment Managers tells Reuters.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.